Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017105
Sloan Kettering Institute
Search grants from Sloan Kettering Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Impact of the senescent bone marrow microenvironment in AML biology
Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina
Vanderbilt ASPIRE Program
Habitual napping in kindergarten: Implications for sleep, AM cortisol and diet
Core - Angiogenesis Genomics and Bioinformatics Core
Recently added grants:
TRP channels as fundamental sensors of the cerebral microcirculation
Multimodal Neuroimaging of Alcohol Withdrawal: The Role of Glutamate in Neural Reorganization
Social affiliation and alcohol drinking in rodents
Innate immune signaling in alcoholic liver disease
Inflammation and alcohol-related racial/ethnic health disparities
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017105-005
Application #
6828837
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Sloan Kettering Institute
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017105
/ Sloan Kettering Institute
Comments
Be the first to comment on this grant